This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Haemoscope Corporation. Active years: 2007-2009.
Company Filing History:
Years Active: 2007-2009
Title: The Innovations of Roger C Carroll
Introduction
Roger C Carroll is a notable inventor based in Knoxville, TN (US). He has made significant contributions to the field of hemostasis through his innovative patents. With a total of 2 patents to his name, Carroll's work focuses on improving the understanding and monitoring of blood hemostasis.
Latest Patents
Carroll's latest patents include a "Protocol and apparatus for determining heparin-induced thrombocytopenia" and a "Protocol for monitoring platelet inhibition." The first patent involves a hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer, which measures the hemostasis process in real time. This technology allows for the determination of heparin-induced thrombocytopenia II complex (HiT II). The second patent also utilizes the TEG® hemostasis analyzer to evaluate platelet inhibition therapy by measuring blood hemostasis parameters continuously.
Career Highlights
Carroll is associated with Haemoscope Corporation, where he applies his expertise in hemostasis analysis. His work has been instrumental in advancing the understanding of blood coagulation and its implications in medical treatments.
Collaborations
Some of his notable coworkers include Eli Cohen and Roslyn Cohen, who have collaborated with him in various projects related to hemostasis and blood analysis.
Conclusion
Roger C Carroll's contributions to the field of hemostasis through his patents and work at Haemoscope Corporation highlight his dedication to advancing medical technology. His innovations continue to impact the understanding and treatment of blood-related conditions.